We assume a 20% reduction in calorie consumption among AOM patients after their weight loss, relative to their original calorie intake
A further increase by 39.8% in obesity-related DALYs and by 42.7% in obesity-related mortality is expected from 2020 to 2030 1
It also lists a wide set of medication options, including GLP-1 receptor agonists and compounded formulations, plus automatic refill reminders
This doesn't mean evening dosing is universally superior
always contact our clinical team
Open Med 15(1):689696 Kojima M, Takahashi H, Kuwashiro T, Tanaka K, Mori H, Ozaki I, Kitajima Y, Matsuda Y, Ashida K, Eguchi Y, Anzai K (2020) Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis